Recommendations for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer

被引：3
|
作者：
Aapro, M. S. [1 ]
Hadji, P. [2 ]
Brufsky, A. [3 ]
Tubana-Hulin, M. [4 ]
Guise, T. [5 ]
Body, J. J. [6 ]
机构：
[1] Doyen IMO Clin De Genolier, Inst Multidisciplinaire Oncol, Genolier, Switzerland
[2] Univ Marburg, Dept Endocrinol & Reprod Med, Marburg, Germany
[3] Univ Pittsburgh, Dept Hematol Oncol, Pittsburgh, PA USA
[4] Ctr Rene Huguenin, Dept Oncol, St Cloud, France
[5] Univ Virginia, Dept Internal Med, Charlottesville, VA USA
[6] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70769-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [1] Prevention of Aromatase Inhibitor-Associated Bone Loss in Women with Breast Cancer: Practical Guidance.
    Hadji, P.
    Aapro, M.
    Brufsky, A.
    Tubiana-Hulin, M.
    Guise, T.
    Body, J.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S443 - S443
  • [2] Practical guidance for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer.
    Hadji P
    Appro M
    Brufsky A
    Tubiona-Hulin M
    Guise T
    Body J J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S37 - S38
  • [3] Managing aromatase inhibitor-associated bone loss in breast cancer
    Lipton, Allan
    Gnant, Michael
    Aapro, Matti
    [J]. WOMENS HEALTH, 2007, 3 (04) : 441 - 448
  • [4] Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
    Hadji, P.
    Aapro, M. S.
    Body, J. J.
    Bundred, N. J.
    Brufsky, A.
    Coleman, R. E.
    Gnant, M.
    Guise, T.
    Lipton, A.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (12) : 2546 - 2555
  • [5] Aromatase Inhibitor-Associated Bone Loss: Screening and Prevention
    White, Matthew
    Barre, Luke
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] Aromatase Inhibitor-Associated Bone Loss
    Bryce, Jane
    Bauer, Martina
    Hadji, Peyman
    [J]. ONCOLOGY NURSING FORUM, 2011, 38 (03) : 273 - 276
  • [7] Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
    Bauer, M.
    Bryce, J.
    Hadji, P.
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 91 - 101
  • [8] Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole
    Brufsky, Adam
    Bundred, Nigel
    Coleman, Robert
    Lambert-Falls, Rosemary
    Mena, Raul
    Hadji, Peyman
    Jin, Lixian
    Schenk, Nora
    Ericson, Solveig
    Perez, Edith A.
    [J]. ONCOLOGIST, 2008, 13 (05): : 503 - 514
  • [9] Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
    Hadji, Peyman
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 69 (01) : 73 - 82
  • [10] Aromatase Inhibitor-Associated Bone Loss Clinical Considerations
    Pant, Shubham
    Shapiro, Charles L.
    [J]. DRUGS, 2008, 68 (18) : 2591 - 2600
12345